Genygi Life Sciences Private Limited
About Genygi Life Sciences Private Limited
Data last updated:
Genygi Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52190DL2019PTC359405. Its GSTIN is 07AAKCP9586B1Z0 (Delhi).
The company has an authorised share capital of ₹2.5 Lakh and a paid-up capital of ₹2.04 Lakh. It is led by director Piyush Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ss – 29 Second Floor, Aditya Mega Mall Plot No.9D, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.27 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹1.76 Lakh (net margin -0.4%) and EBITDA of -₹1.98 Lakh (EBITDA margin -0.5%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 42% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Genygi Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSs – 29 Second Floor, Aditya Mega Mall Plot No.9D, New Delhi, Delhi, India – 110032
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Genygi Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Genygi Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Genygi Life Sciences Private Limited, buy the company report.
Financials of Genygi Life Sciences Private Limited
FY 2025 filings availableGenygi Life Sciences Private Limited reported revenue of ₹4.27 Cr (down 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 42%. EBITDA fell 142% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genygi Life Sciences Private Limited, buy the company report.
Board of directors and KMP of Genygi Life Sciences Private Limited
Genygi Life Sciences Private Limited currently reports 1 director and 1 key managerial person. 6 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vitalii Stavskii | Ceo | 27 Nov 2025 | 0 Years 11 Months | Current |
| Piyush Jain | Director | 05 Aug 2024 | 2 Years 3 Months | Current |
Peer comparison
Genygi Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kamalakshi Marketing Private Limited | ₹4.28 Cr (FY 2025) | 28.0% | Mumbai, Maharashtra, India | |||
| MDS Bio-Analytics Private Limited | ₹4.28 Cr (FY 2025) | -10.0% | Nagpur, Maharashtra, India | |||
| Ergode Trading Private Limited | ₹4.28 Cr (FY 2025) | 95.0% | Mumbai, Maharashtra, India | |||
| Golden Chariot Retreats and Infra Private Limited | ₹4.27 Cr (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| Sarada Seva Sadan Hospital Private Limited | ₹4.27 Cr (FY 2025) | 64.0% | Kolkata, West Bengal, India | |||
| Genygi Life Sciences Private Limitedthis company | ₹4.27 Cr (FY 2025) | -₹1.76 Lakh | -0.4% | -19.0% | New Delhi, Delhi, India | |
| Immunogenic Solutions Private Limited | ₹4.27 Cr (FY 2025) | -26948896.0% | Hyderabad, Telangana, India | |||
| Omkareshwar Paper & Pulp Private Limited | ₹4.27 Cr (FY 2024) | Akbarpur, Uttar Pradesh, India | ||||
| Disnyr Fire Enterprises Private Limited | ₹4.26 Cr (FY 2025) | 29.0% | Pune, Maharashtra, India | |||
| Pzad India Private Limited | ₹4.26 Cr (FY 2025) | 16.0% | Delhi, India | |||
| Yuvan Agro Farmers Producer Company Limited | ₹4.26 Cr (FY 2024) | 262.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Genygi Life Sciences Private Limited, buy the company report.
Auditor
Genygi Life Sciences Private Limited is audited by KPR & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KPR & ASSOCIATES | FY 2022 | 017574C |
Shareholding
The shareholding of Genygi Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Genygi Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Genygi Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genygi Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genygi Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAKCP9586B1Z0 | Delhi | Active | 15 Jan 2020 |
To see the full GST registrations and return filing status of Genygi Life Sciences Private Limited, buy the company report.
Recent activity
Genygi Life Sciences Private Limited has 9 board changes on record since 2021: 3 appointments and 6 cessations. The latest: Vitalii Stavskii was appointed as CEO on 27 Nov 2025.
Frequently asked questions
Genygi Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 December 2019 (7+ years old) and is registered under CIN U52190DL2019PTC359405.
Genygi Life Sciences has 2 current directors and KMP:
- Piyush Jain - Director
- Vitalii Stavskii - Ceo
The latest financial statements of Genygi Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Genygi Life Sciences is 07AAKCP9586B1Z0, registered in Delhi.
The CIN (Corporate Identification Number) of Genygi Life Sciences is U52190DL2019PTC359405. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genygi Life Sciences was incorporated on 27 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Genygi Life Sciences by revenue are Kamalakshi Marketing Private Limited, MDS Bio-Analytics Private Limited, Ergode Trading Private Limited, Golden Chariot Retreats and Infra Private Limited, Sarada Seva Sadan Hospital Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Vitalii Stavskii was appointed as CEO on 27 Nov 2025. Oleg Viacheslavovich Gromov ceased to be Additional Director on 29 Sep 2024. Piyush Jain ceased to be Additional Director on 29 Sep 2024. Genygi Life Sciences has 9 board changes on record in total.
The registered office of Genygi Life Sciences is at Ss – 29 Second Floor, Aditya Mega Mall Plot No.9D, New Delhi, Delhi, India – 110032.
Genygi Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Genygi Life Sciences is compliant as of 09 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
